Michael A. Brown

Partner, Corporate  

San Francisco | Santa Monica 415.875.2432 (SF) 310.434.5401 (SM)


Michael Brown concentrates his practice on strategic counseling to companies, ranging from newly formed startup teams to mature publicly traded corporations, and venture capital firms in a wide variety of corporate transactions, including venture capital financings, mergers and acquisitions, initial and follow-on public offerings, debt financings, and corporate reorganizations. Michael was named among the top attorneys in the United States under the age of 40 by Law360 and he was recognized as an emerging leader in the legal industry by the Daily Journal. He has also been named an LMG Life Sciences Star and been honored by Super Lawyers in each of the past five years.

Representative Mergers and Acquisitions

  • Cepheid sale to Danaher ($4B)
  • Multiple acquisitions for Cisco Systems, including its $3.2B acquisition of WebEx Communications
  • Data Domain sale to EMC Corporation ($2.4B)
  • Opsware sale to Hewlett-Packard ($1.6B)
  • ArcSight sale to Hewlett-Packard ($1.5B)
  • Dermira’s pending sale to Eli Lilly ($1.1B)
  • ​OpenDNS sale to Cisco Systems ($635M)
  • ScoutRFP’s sale to Workday ($540M)
  • Autolist’s sale to CarGurus
  • Coinbase acquisitions of Cipher Browser, Keystone Capital,, Memo.AI and Paradex
  • Alteryx acquisitions of Yhat, Semanta and ClearStory Data​

​Representative Initial Public Offerings and Capital Market Transactions

  • Alteryx initial public offering and follow-on public offering
  • Dermira initial public offering and multiple follow-on public offerings
  • Marin Software initial public offering
  • Silver Spring Networks initial public offering
  • ArcSight initial public offering
  • Dexcom multiple follow-on public offerings” ​
  • Glu Mobile follow-on public offering
  • Alteryx, Cepheid, Dermira and ​Dexcom convertible debt offerings pursuant to Rule 144A

Representati​ve Venture Financings

  • Multiple financings for Uber, including its publicly-announced $3.5B investment by Saudi Arabia’s Public Investment Fund and Series F, Series E and Series D financings
  • Multiple financings for Airbnb, including its publicly-announced $1.5B Series E and $475M Series D financings
  • Multiple financings for Carta, including its $300M Series E and $80M Series D financings
  • Multiple financings for Databricks, including its $400M Series F, $250M Series E, $140M Series D and $60M Series C financings
  • Multiple financings for Illumio, including its $125M Series D financing and $100M Series C financings
  • Multiple financings for Tanium, including its $200M common stock, $100M common stock offering and $120M Series G financings
  • Multiple financings for Doctor on Demand, including its $74M Series C financing
  • Multiple investments representing Agilent Technologies, Andreessen Horowitz, Fidelity Investments and NEA:
    • Agilent Technologies in its $80M investment in and $105M acquisition of Lasergen, in its investment in Mission Bio’s $30M Series B and Purigen’s $26M Series B
    • Andreessen Horowitz in multiple deals, including CipherCloud’s $30M Series A, Twice’s $18.5M Series B, and Walker & Co.’s $6.9M Series A
    • Fidelity Investments in connection with approximately 30 investments, including Carbon’s $200M Series D, Sweetgreen’s $200M financing, Castle Creek Pharma’s $71.8M financing and Cibus’ $70M Series C financing
    • NEA in multiple investments, including Senti Bio’s $53M Series A, Coursera’s $49.5M Series C and Qpex Biopharma’s $33M Series A​